Last reviewed · How we verify

NCT06130072

Hysteroscopic Tubal Occlusion Using Amacrylate With or Without Lipidol in Patients With Hydrosalpinx Prior to IVF

Status unknown Phase 3 Last updated 13 November 2023
What this trial tests

Phase 3 trial testing iso-amyl- 2-cyanoacrylate. in Effectiveness of Isoamyl-2-cyanoacrylate With and Without Ethiodized Oil in Occluding Hydrosalpinx Prior to IVF in 45 participants. Status unknown.

Timeline
10 November 2023
Primary endpoint
10 March 2024
10 March 2024

Quick facts

Lead sponsorAin Shams University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment45
Start date10 November 2023
Primary completion10 March 2024
Estimated completion10 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 25 to 43, female only, with Effectiveness of Isoamyl-2-cyanoacrylate With and Without Ethiodized Oil in Occluding Hydrosalpinx Prior to IVF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hysteroscopic tubal occlusion using iso-amyl- 2-cyanoacrylate with or without Ethiodized oil (Lipidol) in patients with hydrosalpinx prior to IVF

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06130072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing